Senior insider sale
CHIEF MEDICAL OFFICER at OLEMA PHARMACEUTICALS, INC. — senior position signals high conviction
$250.6K
27.80K shares
What this filing means
ZOJWALLA NASEEM plans to sell 27.80K shares of OLEMA PHARMACEUTICALS, INC. valued at approximately $250.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/11/2024ACC: 0001959173-24-008596
Officer· CHIEF MEDICAL OFFICER
Since Jan 2022
27.80K
Shares to sell
$250.6K
Approx. market value
14.52K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
12/10/2024
14.52KTotal acquired14.52K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/10/2024 | Restricted Stock Vesting Compensation | 14.52K | — |
| Total | 14.52K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
13.28K
Market value
$124.5K
12/10/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
14.52K
Market value
$126.1K
12/11/2024
Total
Units
27.80K
Value
$250.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/10/2024 | 13.28K | $124.5K | — | Completed |
| Planned — Approximate Date | ||||
12/11/2024 | 14.52K | $126.1K | NASDAQ | Planned |
| Total | 27.80K | $250.6K | ||